University of Pittsburgh
November 7, 2000

EUROPEAN UNION OFFICIAL TO DISCUSS NEW DRUGS IN THE GLOBAL ECONOMY AT PITT

Contact: 

PITTSBURGH, Nov. 8 -- Fernand Sauer, executive director of the European Agency for the Evaluation of Medicinal Products (EMEA), an agency similar to the U.S. Food and Drug Administration, will speak at the University of Pittsburgh, from noon to 1:15 p.m., on Monday, Nov. 13, in Room A115 (Crabtree Lecture Hall) of the Graduate School of Public Health, 130 DeSoto Street, in Oakland.

Sauer's lecture, "New Drugs in the Global Economy: Risk Assessment and Management in the European Union (EU) and Cooperation With the United States," will review developments in the harmonization of drug approval standards between the European Union and the United States, with a focus on innovative drugs.

Sauer has been executive director of EMEA in London since 1994. A graduate in pharmacy from the University of Strasbourg, he holds a master's degree in European and International Law from the University of Paris II and a number of post-graduate diplomas in public health, pharmaceutical law, and European Community studies.

He held various positions in France as a hospital pharmacist and pharmaceutical inspector at the Ministry of Health. In 1979, he joined the European Commission in Brussels and in 1986 became head of the Pharmaceuticals Unit.

Sauer has been involved in the completion of the European Internal Market; trilateral harmonization of regulatory requirements between Europe, Japan, and the US; and the development of pricing transparency and industrial policy in the pharmaceutical sector. Effective December 2000, Sauer will assume new duties as director for Public Health within the Directorate-General for Health and Consumer Protection of the EU Commission.

Sauer's presentation will be followed by a reception in the Parran Hall lounge (Room 118), and both events are free and open to the public. Sauer's visit is co-sponsored by Pitt's European Union Center (within the University Center for International Studies), the Office of the Senior Vice Chancellor for the Health Sciences, and the School of Pharmacy.

For more information, call 412-624-5404.

- 30 -

11/8/00/mgc